295 related articles for article (PubMed ID: 35033380)
41. Sentinel lymph node mapping with staging lymphadenectomy for patients with endometrial cancer increases the detection of metastasis.
Holloway RW; Gupta S; Stavitzski NM; Zhu X; Takimoto EL; Gubbi A; Bigsby GE; Brudie LA; Kendrick JE; Ahmad S
Gynecol Oncol; 2016 May; 141(2):206-210. PubMed ID: 26905211
[TBL] [Abstract][Full Text] [Related]
42. Sensitivity and negative predictive value for sentinel lymph node biopsy in women with early-stage cervical cancer.
Salvo G; Ramirez PT; Levenback CF; Munsell MF; Euscher ED; Soliman PT; Frumovitz M
Gynecol Oncol; 2017 Apr; 145(1):96-101. PubMed ID: 28188015
[TBL] [Abstract][Full Text] [Related]
43. Identifying safe diagnostic algorithms for sentinel lymph node mapping in high-risk endometrial cancer: The SENTIREC-endo study.
Bjørnholt SM; Mogensen O; Bouchelouche K; Sponholtz SE; Parner ET; Hildebrandt MG; Loft A; Neumann G; Bjørn SF; Dahl K; Markauskas A; Frøding LP; Jensen PT
Gynecol Oncol; 2024 Mar; 182():179-187. PubMed ID: 38335900
[TBL] [Abstract][Full Text] [Related]
44. The Role of Sentinel Lymph Node Mapping in High-grade Endometrial Cancer.
Yu R; Matthews BJ; Beavis AL
Curr Treat Options Oncol; 2022 Oct; 23(10):1339-1352. PubMed ID: 35980519
[TBL] [Abstract][Full Text] [Related]
45. Sentinel Node Biopsy in Endometrial Cancer With Dual Cervical and Fundal Indocyanine Green Injection.
Ruiz R; Gorostidi M; Jaunarena I; Goiri C; Aguerre J; Lekuona A
Int J Gynecol Cancer; 2018 Jan; 28(1):139-144. PubMed ID: 29194192
[TBL] [Abstract][Full Text] [Related]
46. A prospective evaluation of the sentinel node mapping algorithm in endometrial cancer and correlation of its performance against endometrial cancer risk subtypes.
Rajanbabu A; Agarwal R
Eur J Obstet Gynecol Reprod Biol; 2018 May; 224():77-80. PubMed ID: 29554604
[TBL] [Abstract][Full Text] [Related]
47. Impact of sentinel lymph node mapping on survival in patients with high-risk endometrial cancer in the early stage: A matched cohort study.
Jaafar E; Gaultier V; Wohrer H; Estevez JP; Gonthier C; Koskas M
Int J Gynaecol Obstet; 2024 May; 165(2):677-684. PubMed ID: 38226675
[TBL] [Abstract][Full Text] [Related]
48. The Utility of Sentinel Lymph Node Mapping in High-Grade Endometrial Cancer.
Tanner EJ; Ojalvo L; Stone RL; Levinson K; Temkin SM; Murdock T; Vang R; Sinno AK; Fader AN
Int J Gynecol Cancer; 2017 Sep; 27(7):1416-1421. PubMed ID: 30814241
[TBL] [Abstract][Full Text] [Related]
49. The importance of applying a sentinel lymph node mapping algorithm in endometrial cancer staging: beyond removal of blue nodes.
Barlin JN; Khoury-Collado F; Kim CH; Leitao MM; Chi DS; Sonoda Y; Alektiar K; DeLair DF; Barakat RR; Abu-Rustum NR
Gynecol Oncol; 2012 Jun; 125(3):531-5. PubMed ID: 22366409
[TBL] [Abstract][Full Text] [Related]
50. Tips and tricks to improve sentinel lymph node mapping with Indocyanin green in endometrial cancer.
Body N; Grégoire J; Renaud MC; Sebastianelli A; Grondin K; Plante M
Gynecol Oncol; 2018 Aug; 150(2):267-273. PubMed ID: 29909967
[TBL] [Abstract][Full Text] [Related]
51. Technetium-99m-indocyanine green versus technetium-99m-methylene blue for sentinel lymph node biopsy in early-stage endometrial cancer.
Cabrera S; Bebia V; Franco-Camps S; Forcada C; Villasboas-Rosciolesi D; Navales I; Pérez-Benavente A; Gil-Moreno A
Int J Gynecol Cancer; 2020 Mar; 30(3):311-317. PubMed ID: 31992599
[TBL] [Abstract][Full Text] [Related]
52. Role of one-step nucleic acid amplification (OSNA) to detect sentinel lymph node low-volume metastasis in early-stage cervical cancer.
Bizzarri N; Pedone Anchora L; Zannoni GF; Santoro A; Valente M; Inzani F; Gallotta V; Conte C; Chiantera V; Fanfani F; Fagotti A; Ferrandina G; Scambia G
Int J Gynecol Cancer; 2020 Mar; 30(3):364-371. PubMed ID: 31980488
[TBL] [Abstract][Full Text] [Related]
53. Combining Indocyanine Green and Tc
Lührs O; Ekdahl L; Lönnerfors C; Geppert B; Persson J
Gynecol Oncol; 2020 Feb; 156(2):335-340. PubMed ID: 31780237
[TBL] [Abstract][Full Text] [Related]
54. Comparison between laparoscopic and robotic surgery for sentinel lymph node mapping in endometrial cancer using indocyanine green and near infra-red fluorescence imaging.
Chaowawanit W; Campbell V; Wilson E; Chetty N; Perrin L; Jagasia N; Barry S
J Obstet Gynaecol; 2021 May; 41(4):642-646. PubMed ID: 32812452
[TBL] [Abstract][Full Text] [Related]
55. Comparison Study of Laparoscopic Sentinel Lymph Node Mapping in Endometrial Carcinoma Using Carbon Nanoparticles and Lymphatic Pathway Verification.
Zuo J; Wu LY; Cheng M; Bai P; Lei CZ; Li N; Zhang GY; Zhao D; Li B
J Minim Invasive Gynecol; 2019; 26(6):1125-1132. PubMed ID: 30445188
[TBL] [Abstract][Full Text] [Related]
56. Incidence of sentinel lymph node metastases in apparent early-stage endometrial cancer: a multicenter observational study.
De Vitis LA; Fumagalli D; Schivardi G; Capasso I; Grcevich L; Multinu F; Cucinella G; Occhiali T; Betella I; Guillot BE; Pappalettera G; Shahi M; Fought AJ; McGree M; Reynolds E; Colombo N; Zanagnolo V; Aletti G; Langstraat C; Mariani A; Glaser G
Int J Gynecol Cancer; 2024 May; 34(5):689-696. PubMed ID: 38514100
[TBL] [Abstract][Full Text] [Related]
57. Sentinel lymph node mapping in endometrial cancer: a systematic review and meta-analysis.
How JA; O'Farrell P; Amajoud Z; Lau S; Salvador S; How E; Gotlieb WH
Minerva Ginecol; 2018 Apr; 70(2):194-214. PubMed ID: 29185673
[TBL] [Abstract][Full Text] [Related]
58. Sentinel lymph node mapping in endometrial cancer: A comparison of main national and international guidelines.
Dick A; Perri T; Kogan L; Brandt B; Meyer R; Levin G
Int J Gynaecol Obstet; 2023 Jan; 160(1):220-225. PubMed ID: 35700068
[TBL] [Abstract][Full Text] [Related]
59. [Clinical analysis of 76 cases of sentinel lymph node detection in cervical cancer and endometrial cancer].
Liang SC; Wang ZQ; Wang JL
Zhonghua Fu Chan Ke Za Zhi; 2017 Sep; 52(9):605-611. PubMed ID: 28954449
[No Abstract] [Full Text] [Related]
60. Mapping sentinel lymph nodes in early-stage ovarian cancer (MELISA) trial - a further step towards lymphadenectomy replacement.
Agustí N; Vidal-Sicart S; Paredes P; Celada-Castro C; Migliorelli F; Glickman A; Marina T; Fusté P; Carreras-Dieguez N; Saco A; Díaz-Feijóo B; Torné A
Gynecol Oncol; 2023 Dec; 179():145-151. PubMed ID: 37980769
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
